Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Short-Term Outcomes and Safety of Computed Tomography-Guided Percutaneous Microwave Ablation of Solitary Adrenal Metastasis from Lung Cancer: A Multi-Center Retrospective Study

  • Men, Min (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University) ;
  • Ye, Xin (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University) ;
  • Fan, Weijun (Imaging and Interventional Center, Sun Yat-sen University Cancer Center) ;
  • Zhang, Kaixian (Department of Oncology, Teng Zhou Central People's Hospital Affiliated with Jining Medical College) ;
  • Bi, Jingwang (Department of Oncology, Jinan Military General Hospital of Chinese People's Liberation Army) ;
  • Yang, Xia (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University) ;
  • Zheng, Aimin (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University) ;
  • Huang, Guanghui (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University) ;
  • Wei, Zhigang (Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University)
  • Received : 2015.12.28
  • Accepted : 2016.07.09
  • Published : 2016.11.01
⟨ Previous Next ⟩

Abstract

Objective: To retrospectively evaluate the short-term outcomes and safety of computed tomography (CT)-guided percutaneous microwave ablation (MWA) of solitary adrenal metastasis from lung cancer. Materials and Methods: From May 2010 to April 2014, 31 patients with unilateral adrenal metastasis from lung cancer who were treated with CT-guided percutaneous MWA were enrolled. This study was conducted with approval from local Institutional Review Board. Clinical outcomes and complications of MWA were assessed. Results: Their tumors ranged from 1.5 to 5.4 cm in diameter. After a median follow-up period of 11.1 months, primary efficacy rate was 90.3% (28/31). Local tumor progression was detected in 7 (22.6%) of 31 cases. Their median overall survival time was 12 months. The 1-year overall survival rate was 44.3%. Median local tumor progression-free survival time was 9 months. Local tumor progression-free survival rate was 77.4%. Of 36 MWA sessions, two (5.6%) had major complications (hypertensive crisis). Conclusion: CT-guided percutaneous MWA may be fairly safe and effective for treating solitary adrenal metastasis from lung cancer.

Keywords

References

  1. Yamakado K. Image-guided ablation of adrenal lesions. Semin Intervent Radiol 2014;31:149-156 https://doi.org/10.1055/s-0034-1373797
  2. Bradley CT, Strong VE. Surgical management of adrenal metastases. J Surg Oncol 2014;109:31-35 https://doi.org/10.1002/jso.23461
  3. Vazquez BJ, Richards ML, Lohse CM, Thompson GB, Farley DR, Grant CS, et al. Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. World J Surg 2012;36:1400-1405 https://doi.org/10.1007/s00268-012-1506-3
  4. Yamakado K, Anai H, Takaki H, Sakaguchi H, Tanaka T, Kichikawa K, et al. Adrenal metastasis from hepatocellular carcinoma: radiofrequency ablation combined with adrenal arterial chemoembolization in six patients. AJR Am J Roentgenol 2009;192:W300-W305 https://doi.org/10.2214/AJR.08.1752
  5. Mayo-Smith WW, Dupuy DE. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results. Radiology 2004;231:225-230 https://doi.org/10.1148/radiol.2311031007
  6. Xiao YY, Tian JL, Li JK, Yang L, Zhang JS. CT-guided percutaneous chemical ablation of adrenal neoplasms. AJR Am J Roentgenol 2008;190:105-110 https://doi.org/10.2214/AJR.07.2145
  7. Murphy KP, Maher MM, O'Connor OJ. Abdominal ablation techniques. AJR Am J Roentgenol 2015;204:W495-W502 https://doi.org/10.2214/AJR.14.13222
  8. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. J Vasc Interv Radiol 2014;25:1691-1705.e4 https://doi.org/10.1016/j.jvir.2014.08.027
  9. Ward RC, Healey TT, Dupuy DE. Microwave ablation devices for interventional oncology. Expert Rev Med Devices 2013;10:225-238 https://doi.org/10.1586/erd.12.77
  10. Abbas G. Microwave ablation. Semin Thorac Cardiovasc Surg 2011;23:81-83 https://doi.org/10.1053/j.semtcvs.2011.04.003
  11. Ye X, Fan W, Chen JH, Feng WJ, Gu SZ, Han Y, et al. Chinese expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors. Thorac Cancer 2015;6:112-121 https://doi.org/10.1111/1759-7714.12152
  12. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655 https://doi.org/10.1097/00000421-198212000-00014
  13. Ong CK, Lirk P, Seymour RA, Jenkins BJ. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg 2005;100:757-773, table of contents https://doi.org/10.1213/01.ANE.0000144428.98767.0E
  14. Yang X, Ye X, Zheng A, Huang G, Ni X, Wang J, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol 2014;110:758-763 https://doi.org/10.1002/jso.23701
  15. Wei Z, Ye X, Yang X, Huang G, Li W, Wang J, et al. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol 2015;32:464
  16. Lubner MG, Brace CL, Hinshaw JL, Lee FT Jr. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010;21(8 Suppl):S192-S203 https://doi.org/10.1016/j.jvir.2010.04.007
  17. Crocetti L, Bozzi E, Faviana P, Cioni D, Della Pina C, Sbrana A, et al. Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovasc Intervent Radiol 2010;33:818-827 https://doi.org/10.1007/s00270-010-9869-z
  18. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 2009;20(7 Suppl):S377-S390 https://doi.org/10.1016/j.jvir.2009.04.011
  19. Beland MD, Mayo-Smith WW. Ablation of adrenal neoplasms. Abdom Imaging 2009;34:588-592 https://doi.org/10.1007/s00261-008-9462-y
  20. Ethier MD, Beland MD, Mayo-Smith W. Image-guided ablation of adrenal tumors. Tech Vasc Interv Radiol 2013;16:262-268 https://doi.org/10.1053/j.tvir.2013.08.008
  21. Pua BB, Solomon SB. Ablative therapies in adrenal tumors: primary and metastatic. J Surg Oncol 2012;106:626-631 https://doi.org/10.1002/jso.23191
  22. Uppot RN, Gervais DA. Imaging-guided adrenal tumor ablation. AJR Am J Roentgenol 2013;200:1226-1233 https://doi.org/10.2214/AJR.12.10328
  23. Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009;38:135-143 https://doi.org/10.1067/j.cpradiol.2007.10.001
  24. Carrafiello G, Laganà D, Mangini M, Fontana F, Dionigi G, Boni L, et al. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int J Surg 2008;6 Suppl 1:S65-S69 https://doi.org/10.1016/j.ijsu.2008.12.028
  25. Fan W, Li X, Zhang L, Jiang H, Zhang J. Comparison of microwave ablation and multipolar radiofrequency ablation in vivo using two internally cooled probes. AJR Am J Roentgenol 2012;198:W46-W50 https://doi.org/10.2214/AJR.11.6707
  26. Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L. Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 2015;7:1054-1063 https://doi.org/10.4254/wjh.v7.i8.1054
  27. Spiro SG, Rudd RM, Souhami RL, Brown J, Fairlamb DJ, Gower NH, et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 2004;59:828-836 https://doi.org/10.1136/thx.2003.020164
  28. Plönes T, Osei-Agyemang T, Krohn A, Passlick B. Surgical treatment of extrapulmonary oligometastatic non-small cell lung cancer. Indian J Surg 2015;77(Suppl 2):216-220 https://doi.org/10.1007/s12262-012-0771-6
  29. Luketich JD, Burt ME. Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 1996;62:1614-1616 https://doi.org/10.1016/S0003-4975(96)00611-X
  30. Moreno P, de la Quintana Basarrate A, Musholt TJ, Paunovic I, Puccini M, Vidal O, et al. Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery 2013;154:1215-1222; discussion 1222-1223 https://doi.org/10.1016/j.surg.2013.06.021
  31. Porte H, Siat J, Guibert B, Lepimpec-Barthes F, Jancovici R, Bernard A, et al. Resection of adrenal metastases from nonsmall cell lung cancer: a multicenter study. Ann Thorac Surg 2001;71:981-985 https://doi.org/10.1016/S0003-4975(00)02509-1
  32. Desai A, Rai H, Haas J, Witten M, Blacksburg S, Schneider JG. A retrospective review of cyberKnife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop University Hospital experience. Front Oncol 2015;5:185
  33. Soejima T, Hirota S, Hishikawa Y, Hamanaka A, Ozawa Z, Endo M, et al. [Radiation therapy for adrenal metastases]. Nihon Igaku Hoshasen Gakkai Zasshi 1997;57:801-804
  34. Li X, Fan W, Zhang L, Zhao M, Huang Z, Li W, et al. CT-guided percutaneous microwave ablation of adrenal malignant carcinoma: preliminary results. Cancer 2011;117:5182-5188 https://doi.org/10.1002/cncr.26128
  35. Wang Y, Liang P, Yu X, Cheng Z, Yu J, Dong J. Ultrasoundguided percutaneous microwave ablation of adrenal metastasis: preliminary results. Int J Hyperthermia 2009;25:455-461 https://doi.org/10.1080/02656730903066608
  36. Tsoumakidou G, Buy X, Zickler P, Zupan M, Douchet MP, Gangi A. Life-threatening complication during percutaneous ablation of adrenal gland metastasis: Takotsubo syndrome. Cardiovasc Intervent Radiol 2010;33:646-649 https://doi.org/10.1007/s00270-009-9612-9

Cited by

  1. Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity vol.3, pp.4, 2016, https://doi.org/10.1016/j.adro.2018.05.006
  2. Microwave Ablation of Adrenal Tumors in Patients With Continuous Intra-Arterial Blood Pressure Monitoring Without Prior Alpha-Adrenergic Blockade: Safety and Efficacy vol.43, pp.9, 2020, https://doi.org/10.1007/s00270-020-02547-w
  3. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases vol.20, pp.1, 2016, https://doi.org/10.1186/s12885-020-07030-w
  4. Image-Guided Percutaneous Ablation of Adrenal Metastases: A Meta-Analysis of Efficacy and Safety vol.32, pp.4, 2016, https://doi.org/10.1016/j.jvir.2020.12.010
  5. Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation vol.36, pp.3, 2021, https://doi.org/10.3803/enm.2021.1008